• English
    • Deutsch
  • English 
    • English
    • Deutsch
  • Login
View Item 
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
  •   Home
  • Universität Ulm / Medizin
  • Publikationsnachweise
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Advances in the management of HER2-positive early breast cancer

Erstveröffentlichung
2017
Authors
Baselga, Jose
Coleman, Robert E.
Cortes, Javier
Janni, Wolfgang
Wissenschaftlicher Artikel


Published in
Critical Reviews in Oncology/Hematology ; 119 (2017). - S. 113-122. - ISSN 1040-8428. - eISSN 1879-0461
Link to publication
https://dx.doi.org/10.1016/j.critrevonc.2017.10.001
Institutions
UKU. Klinik für Frauenheilkunde und Geburtshilfe
Subject headings
[Free subject headings]: Breast cancer | HER2 | Trastuzumab | T-DM1 | Neratinib | Pertuzumab | Lapatinib | epidermal-growth-factor | pertuzumab plus trastuzumab | randomized phase-3 trial | open-label | adjuvant trastuzumab | double-blind | receptor heterodimerization | chemotherapy plus | tyrosine kinase | follow-up
[DDC subject group]: DDC 610 / Medicine & health

Metadata
Show full item record

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement
 

 

Advanced Search

Browse

All of OPARUCommunities & CollectionsPersonsInstitutionsPublication typesUlm SerialsDewey Decimal ClassesEU projects UlmDFG projects UlmOther projects Ulm

My Account

LoginRegister

Statistics

View Usage Statistics

Policy | kiz service OPARU | Contact Us
Impressum | Privacy statement